Internal Medicine, Infectious Disease · Desoto, TX
NPI
1295993434
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2727 Bolton Boone Dr Ste 109
Desoto, TX, 75115
Phone (972) 283-2370
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
1,409 services
Medicare patients, 2024
350
Average age 74
Drug cost, 2024
$108K
215 prescriptions
Company payments, 2025
$25.7
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Prasanthi Jasty was code 99232 (hospital e&m - subsequent), 759 times for 236 patients. In total Prasanthi Jasty billed 1,409 services in 11 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-06-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 759 | 236 | $57.47 | $44K |
| 99233 Hospital E&M - Subsequent | Facility | 412 | 178 | $86.14 | $35K |
| 99223 Hospital E&M - Initial | Facility | 162 | 143 | $125.49 | $20K |
| 99214 Office E&M - Established | Office | 62 | 34 | $87.86 | $5,447 |
By year: 2022 $132K for 1,947 services; 2023 $114K for 1,561 services; 2024 $106K for 1,409 services.
Medicare prescription drug claims, 2024
In 2024, the drug Prasanthi Jasty prescribed most often to Medicare patients was Daptomycin, with 33 prescriptions and refills. In total Prasanthi Jasty wrote 215 Medicare prescriptions that cost $108K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 33 | 33 | Under 11 | $5,747 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 18 | 18 | Under 11 | $67K |
| Ceftriaxone Ceftriaxone Sodium | 17 | 17 | Under 11 | $1,483 |
| Ertapenem Ertapenem Sodium | 17 | 17 | Under 11 | $4,412 |
| Cefepime Cefepime In Iso-Osm Dextrose | 16 | 16 | Under 11 | $6,023 |
| Cefepime Hcl Generic | 16 | 16 | Under 11 | $3,080 |
| Meropenem Generic | 13 | 13 | Under 11 | $4,096 |
| Vancomycin Hcl Generic | 11 | 11 | Under 11 | $1,146 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 11 | 11 | Under 11 | $175 |
Brand drugs: 59 claims; generic drugs: 156 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Prasanthi Jasty $25.7 ($25.7 in general payments such as food, travel and fees) from 1 company. The largest payer was Merck Sharp & Dohme LLC with $25.7.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 1 | $25.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.